SB01 / Sinphar Pharma, National Health Research Institutes  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
SB01 / Sinphar Pharma
NCT02488629: Study of SCB01A in Patient With Head and Neck Cancer

Terminated
2
5
RoW
SCB01A
SynCore Biotechnology Co., Ltd.
Head and Neck Squamous Cell Carcinoma
12/17
12/17
NCT03020823: To Evaluate the Efficacy and Safety of SCB01A in Subjects With r/m Squamous Cell Head and Neck Cancer

Terminated
2
10
RoW
SCB01A, 6-Methoxy-3-(3',4',5'-trimethoxybenzoyl) indole
SynCore Biotechnology Co., Ltd.
Head and Neck Neoplasms
11/18
11/18

Download Options